borderline ovarian tumors

Cell proliferation activity unrelated to COX-2 expression in ovarian tumors
A. Yoshida, L. O. Sarian, L. A.L.A. Andrade, F. Pignataro, G. A. Pinto, S. F.M. Derchain

International Journal of Gynecologic Cancer May 2007, 17 (3) 607-614; DOI: 10.1136/ijgc-00009577-200705000-00009
HER-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization
J. K. R. HEINRICH, F. BÖTTCHER-LUIZ, L. L. A. ANDRADE, S. DAVIDSON, L. BONDS, J. STEPHENS, M. VARELLA-GARCIA

International Journal of Gynecologic Cancer Nov 2004, 14 (6) 1078-1085; DOI: 10.1136/ijgc-00009577-200411000-00004
An in vitro study of ovarian atypical proliferating (borderline) serous tumors
C. VAN HAAFTEN-DAY, P. RUSSELL, S. DAVIES, S. BRAMMAH-CARR

International Journal of Gynecologic Cancer Jan 1992, 2 (1) 41-48; DOI: 10.1046/j.1525-1438.1992.02010041.x

Main menu